Monday, June 30, 2025 6/30/2025

Mg-based therapy for mitigating HAND and neuropsychiatric symptoms in the condition of chronic HIV infection

Award Number: R21AG090171
ORGANIZATION: NATIONAL INSTITUTE ON AGING
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 09/20/2024
PERIOD OF PERFORMANCE END DATE: 08/31/2026

Group Awards By:

View Award Description

Mg-based therapy for mitigating HAND and neuropsychiatric symptoms in the condition of chronic HIV infection - Abstract Microglia (Mg), the brain residential macrophage, play critical roles in maintaining adult brain homeostasis. Mg can function as multi-players such as housekeepers, guards, and warriors under both physiological and pathological conditions. Accumulating evidence reveal that Mg also play vital roles in brain aging. Reversing or eliminating senescent Mg and replenishing with new-born Mg have been suggested as treatment for aging and neurodegenerative disease. Recently, Mg depletion and repopulation (MgDR) has been tested as a potential therapeutic approach for acute brain injury and Alzheimer’s diseases. Mechanically, the repopulated Mg show homeostatic phenotype with restoring BDNF signaling or increasing the activity of IL6 pathway to improve brain functions. It has been well-accepted that sustained and lower levels of Mg activation promote Mg senescence and contribute to HAND pathogenesis. Several anti-neuroinflammatory drugs have been proposed as alternative approach for HAND therapy. However, whether MgDR could be a novel therapeutic approach to mitigate neurological deficiency in chronic HIV (+) individuals have never been explored. We initiated pilot studies and obtained these preliminary data: (1) Both HIV transgenic (Tg) rats and HIV-inducible (i) mice show increased LDAM in the brains compared to age-matched counterparts; (2) HIV-iTAT mice show dysregulated lipid profile in the brain hippocampus; (3) MgDR by PLX3397 restored locomotion coordination ability in HIV-iTAT male mice. Based on these observations, we hypothesize that LDAM contribute to the pathogenesis of HAND and neuropsychiatric symptoms and MgDR can exert therapeutic effects on brain dysfunctions in the context of chronic HIV infection. The hypothesis will be tested in the following two specific aims (SA): SA1: Investigate the effects of MgDR on HAND and neuropsychiatric symptoms in HIV-Tg26 mice. SA2: Explore the detailed mechanisms underlying the effects of MgDR on brain pathology in vivo. This proposal will explore the therapeutic effects of MgDR on brain pathology in the context of chronic HIV infection. If succeed, we could open a new research direction to identify effective therapy to improve the life-quality of chronic HIV (+) individuals.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $0 )
2025	2024	OLD DOMINION UNIVERSITY	HAMPTON BLVD	NORFOLK	VA	23529	NORFOLK CITY	USA	Aging Research	000	1	11/21/2024	NEW	$0
														Subtotal = $0

Issue Date FY: 2024 ( Subtotal = $440,000 )
2024	2024	OLD DOMINION UNIVERSITY	HAMPTON BLVD	NORFOLK	VA	23529	NORFOLK CITY	USA	Aging Research	000	1	9/19/2024	NEW	$440,000
														Subtotal = $440,000

Grand Total All Awards = $440,000

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Mg-based therapy for mitigating HAND and neuropsychiatric symptoms in the condition of chronic HIV infection

Award Number: R21AG090171

ORGANIZATION: NATIONAL INSTITUTE ON AGING

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 09/20/2024

PERIOD OF PERFORMANCE END DATE: 08/31/2026

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer